Mallinckrodt Hosp Drug Patent Portfolio
Mallinckrodt Hosp owns 1 orange book drug protected by 11 US patents Given below is the list of Mallinckrodt Hosp's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9399012 | Reduced dose intravenous acetaminophen | 11 Mar, 2032 | Active |
| US9399012 | Reduced dose intravenous acetaminophen | 11 Sep, 2031 | Active |
| US9610265 | Reduced dose intravenous acetaminophen | 13 May, 2029 | Active |
| US9987238 | Reduced dose intravenous acetaminophen | 13 May, 2029 | Active |
| US10383834 | Reduced dose intravenous acetaminophen | 13 Nov, 2028 | Active |
| US9610265 | Reduced dose intravenous acetaminophen | 13 Nov, 2028 | Active |
| US9987238 | Reduced dose intravenous acetaminophen | 13 Nov, 2028 | Active |
| US6992218 | Method for obtaining aqueous formulations of oxidation-sensitive active principles | 06 Dec, 2021 | Expired |
| US6992218 | Method for obtaining aqueous formulations of oxidation-sensitive active principles | 06 Jun, 2021 | Expired |
| US6028222 | Stable liquid paracetamol compositions, and method for preparing same | 05 Feb, 2018 | Expired |
| US6028222 | Stable liquid paracetamol compositions, and method for preparing same | 05 Aug, 2017 | Expired |
Latest Legal Activities on Mallinckrodt Hosp's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mallinckrodt Hosp.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Jan, 2024 | US9399012 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 20 Feb, 2023 | US10383834 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 06 Dec, 2021 | US9987238 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 Sep, 2020 | US9610265 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 27 Jan, 2020 | US9399012 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Aug, 2019 | US10383834 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Aug, 2019 | US10383834 |
|
Email Notification
Critical
| 01 Aug, 2019 | US10383834 |
|
Issue Notification Mailed
Critical
| 31 Jul, 2019 | US10383834 |
| Dispatch to FDC | 22 Jul, 2019 | US10383834 |
|
Application Is Considered Ready for Issue
Critical
| 12 Jul, 2019 | US10383834 |
|
Issue Fee Payment Verified
Critical
| 03 Jul, 2019 | US10383834 |
|
Issue Fee Payment Received
Critical
| 03 Jul, 2019 | US10383834 |
|
Email Notification
Critical
| 22 May, 2019 | US10383834 |
| Mail Miscellaneous Communication to Applicant | 22 May, 2019 | US10383834 |
Mallinckrodt Hosp's Family Patents
Mallinckrodt Hosp drugs have patent protection in a total of 3 countries. It has a significant patent presence in the US with 75.0% of its patents being US patents. Click
below to unlock the full patent family tree.
Mallinckrodt Hosp Drug List
Given below is the complete list of Mallinckrodt Hosp's drugs and the patents protecting them.
1. Ofirmev
Ofirmev is protected by 11 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9399012
(Pediatric)
| Reduced dose intravenous acetaminophen |
11 Mar, 2032
(6 years from now)
| Active |
| US9399012 | Reduced dose intravenous acetaminophen |
11 Sep, 2031
(5 years from now)
| Active |
| US9610265
(Pediatric)
| Reduced dose intravenous acetaminophen |
13 May, 2029
(3 years from now)
| Active |
| US9987238
(Pediatric)
| Reduced dose intravenous acetaminophen |
13 May, 2029
(3 years from now)
| Active |
| US10383834 | Reduced dose intravenous acetaminophen |
13 Nov, 2028
(3 years from now)
| Active |
| US9610265 | Reduced dose intravenous acetaminophen |
13 Nov, 2028
(3 years from now)
| Active |
| US9987238 | Reduced dose intravenous acetaminophen |
13 Nov, 2028
(3 years from now)
| Active |
| US6992218
(Pediatric)
| Method for obtaining aqueous formulations of oxidation-sensitive active principles |
06 Dec, 2021
(3 years ago)
| Expired |
| US6992218 | Method for obtaining aqueous formulations of oxidation-sensitive active principles |
06 Jun, 2021
(4 years ago)
| Expired |
| US6028222
(Pediatric)
| Stable liquid paracetamol compositions, and method for preparing same |
05 Feb, 2018
(7 years ago)
| Expired |
| US6028222 | Stable liquid paracetamol compositions, and method for preparing same |
05 Aug, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ofirmev's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List